October 20, 2021 Enzychem Lifesciences Announces Positive Results for Phase 2 U.S. Study of EC-18 in Chemoradiation-Induced Oral Mucositis Explore further
September 13, 2021 Enzychem Lifesciences Announces Database Lock for Phase 2 Study of EC-18 in Chemoradiation-Induced Oral Mucositis Explore further
May 20, 2021 Enzychem Lifesciences Announces Poster Presentation at the 2021 Keystone Symposia Conference Explore further
April 20, 2021 Enzychem Lifesciences Selected to Collaborate with NIAID CCRP on the CERF Program Explore further
April 16, 2021 Enzychem Lifesciences Announces Oral Presentation of TLR Signaling Inhibition with Mosedipimod (EC-18) at The International Liver Congress 2021 (EASL) Explore further
